Remicade News
Most Popular Remicade Story
MAbs are hottest segment of biotech industry
Looking for the hottest segment of the biotech industry? Then take a look at monoclonal antibodies (mAbs). A new Datamonitor report projects 14 percent annual growth in the market for the antibody... Read more...
Latest Headlines
- October 3, 2008
- November 8, 2007
- October 12, 2007
- February 1, 2007
- October 26, 2006
- August 13, 2006
- March 8, 2006
- December 19, 2005
- October 13, 2005
- August 15, 2005
- August 11, 2005
Paid Research Reports
- The Specialty Pharma Market Outlook: Key players, new company growth models and emerging opportunities
- Investigating Clinical Trial Costs: Comparative analysis of trial cost components in key geographies
- Clinical Trial Recruitment Strategies: Optimizing patient recruitment and retention in late stage clinical trials
- Pipeline Insight: Therapeutic Cancer Vaccines - Prospect of first approval set to reinvigorate interest from major companies
- Stakeholder Opinions: Vaccines in Emerging Markets (Asia) - Opportunities in China, India, South Korea and Taiwan
- Big Pharma Performance Before, During and Beyond the Global Recession
